Johnson & Johnson CEO says his company has been humbled by all of their recalls, and are on the way to fixing their troubles. That’s a lot of fixing to do.
As previously reported, on February 20, 2010, an investigative report in the New York Times found that hundreds of people taking Avandia needlessly suffer heart attacks and heart failure every month. About 500 heart attacks and 300 cases of heart failure would be averted every month if consumers switched to alternative medicines. Why the delay in a recall?
Today the New York Times published an expose on Avandia, providing damning evidence that the GlaxoSmithKline drug causes an unnecessary increase in risk of heart failure and heart attacks in its users. During the third quarter of 2009, over 300 deaths have allegedly been caused by Avandia.
Twitter
Facebook
Follow us on: